The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
A Multicentre Study of Shigella Diarrhoea in Six Asian Countries: Disease Burden, Clinical Manifestations, and Microbiology
Open accessAbstract
BACKGROUND: The burden of shigellosis is greatest in resource-poor countries. Although this diarrheal disease has been thought to cause considerable morbidity and mortality in excess of 1,000,000 deaths globally per year, little recent data are available to guide intervention strategies in Asia. We conducted a prospective, population-based study in six Asian countries to gain a better understanding of the current disease burden, clinical manifestations, and microbiology of shigellosis in Asia. METHODS AND FINDINGS: Over 600,000 persons of all ages residing in Bangladesh, China, Pakistan, Indonesia, Vietnam, and Thailand were included in the surveillance. Shigella was isolated from 2,927 (5%) of 56,958 diarrhoea episodes detected between 2000 and 2004. The overall incidence of treated shigellosis was 2.1 episodes per 1,000 residents per year in all ages and 13.2/1,000/y in children under 60 months old. Shigellosis incidence increased after age 40 years. S. flexneri was the most frequently isolated Shigella species (1,976/2,927 [68%]) in all sites except in Thailand, where S. sonnei was most frequently detected (124/146 [85%]). S. flexneri serotypes were highly heterogeneous in their distribution from site to site, and even from year to year. PCR detected ipaH, the gene encoding invasion plasmid antigen H in 33% of a sample of culture-negative stool specimens. The majority of S. flexneri isolates in each site were resistant to amoxicillin and cotrimoxazole. Ciprofloxacin-resistant S. flexneri isolates were identified in China (18/305 [6%]), Pakistan (8/242 [3%]), and Vietnam (5/282 [2%]). CONCLUSIONS: Shigella appears to be more ubiquitous in Asian impoverished populations than previously thought, and antibiotic-resistant strains of different species and serotypes have emerged. Focusing on prevention of shigellosis could exert an immediate benefit first by substantially reducing the overall diarrhoea burden in the region and second by preventing the spread of panresistant Shigella strains. The heterogeneous distribution of Shigella species and serotypes suggest that multivalent or cross-protective Shigella vaccines will be needed to prevent shigellosis in Asia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
J Antimicrob Chemother 1994; 33: 350–351
O'SHAUGHNESSY, E. M., & DAS, S. S. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/33.2.350 · Cited by 3,746
Interval estimation for the difference between independent proportions: comparison of eleven methods
Newcombe, R. G. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19980430)17:8<873::aid-sim779>3.0.co;2-i · Cited by 1,851
Kotloff, K. L., Winickoff, J. P., Ivanoff, B., Clemens, J. D., Swerdlow, D. L., Sansonetti, P. J., Adak, G. K., & Levine, M. M. (1999) · Europe PMC (PubMed Central) · Cited by 1,242
Self-citationCohen, D., Ashkenazi, S., Green, M. S., Gdalevich, M., Robin, G., SLEPON, R., Yavzori, M., Orr, N., Block, C., Ashkenazi, I., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(96)06255-1 · Cited by 262
Vaccination against Shigellosis with Attenuated Shigella flexneri 2a Strain SC602
Coster, T. S., Hoge, C. W., VanDeVerg, L. L., Hartman, A. B., Oaks, E. V., Venkatesan, M. M., Cohen, D., Robin, G., Fontaine-Thompson, A., Sansonetti, P. J., et al. (1999) · Infection and Immunity · doi:10.1128/iai.67.7.3437-3443.1999 · Cited by 228
Ferreccio, C., Prado, V., Ojeda, A., Cayyazo, M., Abrego, P., Guers, L., & Levine, M. M. (1991) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116134 · Cited by 214
Thiem, V. D., Sethabutr, O., von Seidlein, L., Van Tung, T., Canh, D. G., Chien, B. T., Tho, L. H., Lee, H., Houng, H.-S., Hale, T. L., et al. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.5.2031-2035.2004 · Cited by 211
Self-citation(2004) · CRC Press eBooks · doi:10.1201/9781439834404 · Cited by 181
Laboratory-Confirmed Shigellosis in the United States, 1989-2002: Epidemiologic Trends and Patterns
Gupta, A., Polyak, C. S., Bishop, R. D., Sobel, J., & Mintz, E. D. (2004) · Clinical Infectious Diseases · doi:10.1086/386326 · Cited by 167
Strategy for Cross-Protection among Shigella flexneri Serotypes
Noriega, F. R., Liao, F. M., Maneval, D. R., et al. (1999) · Infection and Immunity · doi:10.1128/iai.67.2.782-788.1999 · Cited by 144
Cited by
Recent Advances in Understanding Enteric Pathogenic Escherichia coli
Croxen, M. A., Law, R. J., Scholz, R., Keeney, K. M., Wlodarska, M., & Finlay, B. B. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00022-13 · Cited by 1,569
Liu, J., Platts-Mills, J. A., Juma, J., Kabir, F., Nkeze, J., Okoi, C., Operario, D. J., Uddin, J., Ahmed, S., Alonso, P. L., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31529-x · Cited by 865
Self-citationSchroeder, G. N., & Hilbi, H. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00032-07 · Cited by 621
Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road
Levine, M. M., Kotloff, K. L., Barry, E. M., Pasetti, M. F., & Sztein, M. B. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1662 · Cited by 372
Self-citationMokomane, M., Kasvosve, I., Melo, E. D., Pernica, J. M., & Goldfarb, D. M. (2018) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936117744429 · Cited by 262
Metadata
- Authors
- von Seidlein, L., Kim, D. R., Ali, M., Lee, H., Wang, X., Thiem, V. D., Canh, D. G., Chaicumpa, W., Agtini, M. D., Hossain, A., Bhutta, Z. A., Mason, C., Sethabutr, O., Talukder, K., Nair, G. B., Deen, J. L., Kotloff, K., & Clemens, J.
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2006-09-12
- Volume
- 3
- Issue
- 9
- Pages
- e353
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2166293389
- Cited by
- 484
- References
- 23
- FWCI
- 30.89
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Multicentre Study of Shigella Diarrhoea in Six Asian Countries: Disease Burden, Clinical Manifestations, and Microbiology. https://app.cochat.ai/papers/10.1371/journal.pmed.0030353
- The paper
- von Seidlein, L., Kim, D. R., Ali, M., Lee, H., Wang, X., Thiem, V. D., Canh, D. G., Chaicumpa, W., Agtini, M. D., Hossain, A., Bhutta, Z. A., Mason, C., Sethabutr, O., Talukder, K., Nair, G. B., Deen, J. L., Kotloff, K., & Clemens, J. (2006). A Multicentre Study of Shigella Diarrhoea in Six Asian Countries: Disease Burden, Clinical Manifestations, and Microbiology. PLoS Medicine. https://doi.org/10.1371/journal.pmed.0030353
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.